Congressman Tom Kean, who represents New Jersey’s 7th district in the U.S. Congress, announced on July 16, 2025, that his bill, the Promoting United States Wireless Leadership Act, has passed the House with bipartisan support.
In a post made at 13:02 UTC on July 16, Kean stated: “My bill, the Promoting United States Wireless Leadership Act, passed the House with bipartisan support! As the global competition for 5G and wireless technology intensifies, the United States must lead—not follow. This legislation ensures that American innovation, not that of https://t.co/bdFn4YOqx5”.
Later that day at 14:36 UTC, he reiterated the news by posting: “ICYMI: This week, the House passed my bill, the Promoting United States Wireless Leadership Act, to ensure American innovation sets the standard for the future of wireless communications. https://t.co/75miNE9Yfn”.
Kean also highlighted New Jersey’s role in pharmaceutical innovation. At 18:08 UTC on July 16 he wrote: “New Jersey is a leader in innovation, especially in over-the-counter (OTC) drugs. Americans rely on these products every day, and while many have been around for years, companies are always working to make them better. Five years ago, Congress, industry, and the FDA updated the https://t.co/RWHijda5nX”.
Thomas Kean Jr., born in Livingston in 1968 and currently residing in Westfield, began representing New Jersey’s 7th district in Congress after replacing Tom Malinowski in 2023. He previously served both in the New Jersey General Assembly and Senate over two decades of public service. Kean holds a Bachelor of Arts degree from Dartmouth College.
